Volume 12, Number 1—January 2006
Vaccines and Antiviral Drugs in Pandemic Preparedness
|Year of recognition||Old terminology||Molecular antigenic terminology|
*Unknown N subtype.
†Limited human-to-human transmission.
Page created: February 16, 2012
Page updated: February 16, 2012
Page reviewed: February 16, 2012
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.